The company got some bad news to start 2026.

Eli Lilly (LLY) has drawn fresh attention after recent price moves, with the share closing at $1,038.40. Short term returns ...

The pharmaceutical leader continues to grab headlines.

Let's consider three of them: Eli Lilly ( LLY +0.52%), AbbVie ( ABBV 0.31%), and Intuitive Surgical ( ISRG 1.15%). Here's why ...

Healthcare, retail and finance stocks could do well in 2026. See five picks that experts say could have major upside ...

Novo Nordisk A/S is rated a buy, driven by FDA approval of its oral Wegovy, strong fundamentals, and attractive valuation versus Eli Lilly. Recent clinical data and first-mover advantage position ...

Hold iShares U.S. Healthcare ETF (IYH): top holdings face GLP-1 risks, patent cliffs and high valuations. Read here for an ...

If you’re even thinking about retirement, one of the last things you need to worry about is consistent cash flow. Instead, ...

Pfizer Inc. (NYSE:PFE) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported on January 20 that Britain ...

Eli Lilly (NYSE: LLY) is close to doing something no other pharmaceutical company has ever done: reaching $1 trillion in market value. The company briefly touched that level in November but has since ...

The company is benefiting mightily from its portfolio of weight-loss drugs.

We came across a bearish thesis on Alexandria Real Estate Equities, Inc. on Compounding Dividends’s Substack by TJ ...